• Profile
Close

A pilot study of intralesional methotrexate injections vs triamcinolone acetonide in patients affected by nail matrix psoriasis

Clinical and Experimental Dermatology Feb 08, 2022

This study reveals outcomes in 12 patients presenting with nail matrix psoriasis, limited to few nails, treated with intralesional injections of 25mg/ml methotrexate or 10mg/ml triamcinolone acetonide. Comparison was made between both options for response to therapy and follow-up results.

  • Every 6 weeks for 24 weeks, patients received treatments and then observed for 6 months.

  • During each session and at each follow up visit, a photographic documentation and a NAPSI scoring were obtained.

  • At the end of the 4 sessions, disease improved in all cases and these data were corroborated at follow up particularly for the methotrexate treated group.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay